CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 21 - 30 of 847
Study Number Lead Group Study Title CIRB Study Status
A211701 Alliance A Prospective Study to Establish a New Onset Hyperglycemia and Diabetes (NOD) Cohort Cancer Prevention and Control CIRB Available to Open
A031201 Alliance Phase III Trial of Enzalutamide (NSC # 766085) Versus Enzalutamide; Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer Adult CIRB - Late Phase Emphasis Available to Open
A071701 Alliance Genomically-Guided Treatment Trial in Brain Metastases Adult CIRB - Late Phase Emphasis Available to Open
A221504 Alliance A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer Cancer Prevention and Control CIRB Available to Open
A011203 Alliance A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCL in Postmenopausal Women with Metastatic; Estrogen Receptor Positive; HER2 Negative Breast Cancer Adult CIRB - Early Phase Emphasis Available to Open
A071702 Alliance A Phase II Study of Checkpoint Blockade Immunotherapy in Patients with Somatically Hypermutated Recurrent Glioblastoma Adult CIRB - Late Phase Emphasis Available to Open
A171901 Alliance Older Non-Small Cell Lung Cancer Patients (>/= 70 Years of Age) Treated with First-Line MK-3475 (Pembrolizumab) +/- Chemotherapy (Oncologist's/Patient's Choice) Cancer Prevention and Control CIRB Available to Open
A081105 Alliance Randomized Study of Erlotinib Vs Observation in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC) Adult CIRB - Late Phase Emphasis Available to Open
A091401 Alliance Randomized Phase II Study Of Nivolumab With Or Without Ipilimumab In Patients With Metastatic Or Unresectable Sarcoma Adult CIRB - Late Phase Emphasis Available to Open
A031701 Alliance A Phase II Study of Dose-Dense Gemcitabine Plus Cisplatin (DDGC) in Patients with Muscle-Invasive Bladder Cancer with Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations Adult CIRB - Late Phase Emphasis Available to Open
Displaying 21 - 30 of 847